Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study
Completed
Conditions studied: Localized Non-Resectable Adult Liver Carcinoma
In brief
This research registry studies Yttrium Y 90 resin microspheres in collecting data from patients with liver cancer not capable of being removed by surgery (unresectable) for the radiation-emitting Selective Internal Radiation-Spheres (SIR-spheres) in non-resectable (RESIN) liver tumor registry. The information generated will help doctors better understand treatment patterns involving Y90 therapy, gain additional insights in the long-term outcomes for patients, as well as guide future research for using Y90 therapy, especially for those conditions where data is currently very limited or lacking.
Key facts
- Study ID
- NCT02685631
- Run by
- Vanderbilt-Ingram Cancer Center
- People needed
- 1653
- Starts
- 2015-07-01
- Expected to finish
- 2021-08-31
- Last updated by the study team
- 2021-09-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients receiving SIR-Spheres therapy to the liver for the first time.
- Provision of written informed consent.
- Age 18 and older.
You may not qualify if…
- Prior completion of Y90 therapy to the liver (SIR-Spheres, TheraSpheres, or any other liver-targeted therapy involving the use of radiation-emitting spheres).
- Patients who have received Y90 treatment in the past and who are returning for another Y90 treatment are ineligible, even if new areas are being targeted.
- Need for surrogate consent. Patients unable to consent on their own behalves are not eligible for this study.
Where it is running
- University of Alabama — Birmingham, Alabama, United States
- University of Arizona Health Sciences — Tucson, Arizona, United States
- University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Cedars-Sinai Medical Center — Los Angeles, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- University of California, San Francisco — San Francisco, California, United States
- Stanford University — Stanford, California, United States
- University of Colorado, Denver — Denver, Colorado, United States
- Sky Ridge Medical Center — Englewood, Colorado, United States
- Christiana Care Health System — Wilmington, Delaware, United States
- Georgetown University — Washington D.C., District of Columbia, United States
- Baptist Hospital of Miami — Miami, Florida, United States
- University of Miami — Miami, Florida, United States
- Sarasota Memorial Hospital — Sarasota, Florida, United States
- Tampa General Hospital — Tampa, Florida, United States
- Cancer Treatment Centers of America — Atlanta, Georgia, United States
- Emory University — Atlanta, Georgia, United States
- Piedmont Hospital — Atlanta, Georgia, United States
- Advocate Christ Medical Center — Oak Lawn, Illinois, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- Ochsner Clinic Foundation — New Orleans, Louisiana, United States
- University of Maryland School of Medicine — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Saint Louis University — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.